CH
LMDXW

CVS Health’s LumiraDx Limited Warrant LMDXW Stock Holding History

CVS Health’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,352,106
Closed -$72.8K – 6
2024
Q2 		$72.8K Hold
5,352,106
– – 0.03% 6
2024
Q1 		$40.7K Hold
5,352,106
– – 0.02% 6
2023
Q4 		$337K Hold
5,352,106
– – 0.17% 4
2023
Q3 		$1.27M Hold
5,352,106
– – 0.68% 6
2023
Q2 		$2.57M Hold
5,352,106
– – 1.33% 6
2023
Q1 		$2.49M Hold
5,352,106
– – 1.48% 6
2022
Q4 		$4.82M Hold
5,352,106
– – 4.15% 4
2022
Q3 		$5.46M Hold
5,352,106
– – 5.24% 4
2022
Q2 		$14.2M Sell
5,352,106
-179,260
-3% -$155K 11.8% 4
2022
Q1 		$33.2M Sell
5,531,366
-43,047
-0.8% -$55.4K 22.29% 2
2021
Q4 		$49.7M Buy
+5,574,413
New +$9M 43.45% 2

Other funds holding LMDXW

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

CVS Health's LMDXW Position: Q3 2024 in Review

CVS Health sold out of LumiraDx Limited Warrant (LMDXW) in Q3 2024, closing a stake of 5,352,106 shares — an estimated $72.8K sold.

CVS Health first reported a position in LMDXW in Q4 2021 and held it in 11 quarters. The position peaked at $49.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds LMDXW as of Q3 2024.

  • CVS Health reported no remaining LumiraDx Limited Warrant position as of Q3 2024 after selling out during the quarter.
  • CVS Health sold 5,352,106 LumiraDx Limited Warrant shares in Q3 2024, an estimated $72.8K.
  • CVS Health first reported a position in LumiraDx Limited Warrant in Q4 2021 and held it in 11 quarters.
  • CVS Health's LumiraDx Limited Warrant position peaked at $49.7M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q3 2024.

Based on CVS Health's 13F filing for Q3 2024, filed 8 Nov 2024.